XML 46 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes
12 Months Ended
Dec. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

Note 22. Income Taxes

The company’s provision for income tax expense (benefit) consists of the following for Fiscal 2023, 2022, and 2021 (amounts in thousands):

 

 

 

Fiscal 2023

 

 

Fiscal 2022

 

 

Fiscal 2021

 

Current Taxes:

 

 

 

 

 

 

 

 

 

Federal

 

$

63,351

 

 

$

54,462

 

 

$

46,018

 

State

 

 

13,680

 

 

 

14,409

 

 

 

11,790

 

 

 

 

77,031

 

 

 

68,871

 

 

 

57,808

 

Deferred Taxes:

 

 

 

 

 

 

 

 

 

Federal

 

 

(36,474

)

 

 

3,508

 

 

 

6,946

 

State

 

 

(6,866

)

 

 

(2,062

)

 

 

(169

)

 

 

 

(43,340

)

 

 

1,446

 

 

 

6,777

 

Income tax expense

 

$

33,691

 

 

$

70,317

 

 

$

64,585

 

Income tax expense differs from the amount computed by applying the applicable U.S. federal income tax rate of 21% because of the effect of the following items for Fiscal 2023, 2022 and 2021 (amounts in thousands):

 

 

 

Fiscal 2023

 

 

Fiscal 2022

 

 

Fiscal 2021

 

Tax at U.S. federal income tax rate

 

$

32,992

 

 

$

62,729

 

 

$

56,862

 

State income taxes, net of federal income tax benefit

 

 

5,383

 

 

 

9,754

 

 

 

9,181

 

Net share-based windfalls

 

 

(1,960

)

 

 

(2,219

)

 

 

(104

)

Excess executive compensation

 

 

1,950

 

 

 

2,218

 

 

 

1,480

 

Tax credits

 

 

(2,655

)

 

 

(2,263

)

 

 

(2,506

)

Other

 

 

(2,019

)

 

 

98

 

 

 

(328

)

Income tax expense

 

$

33,691

 

 

$

70,317

 

 

$

64,585

 

In Fiscal 2023, 2022 and 2021, the most significant difference in the effective rate and the statutory rate was state income taxes.

Deferred tax assets (liabilities) are comprised of the following (amounts in thousands):

 

 

 

December 30, 2023

 

 

December 31, 2022

 

Self-insurance

 

$

8,478

 

 

$

6,507

 

Compensation and employee benefits

 

 

10,292

 

 

 

9,991

 

Deferred income

 

 

2,643

 

 

 

3,834

 

Loss and credit carryforwards

 

 

13,111

 

 

 

13,138

 

Equity-based compensation

 

 

8,636

 

 

 

7,692

 

Legal accrual

 

 

33,407

 

 

 

1,369

 

Pension and postretirement benefits

 

 

 

 

 

384

 

Financing and operating lease right-of-use liabilities

 

 

72,011

 

 

 

72,470

 

Capitalized software and research and development costs

 

 

32,519

 

 

 

14,898

 

Other

 

 

9,975

 

 

 

7,101

 

Valuation allowance

 

 

(1,586

)

 

 

(1,030

)

Deferred tax assets

 

 

189,486

 

 

 

136,354

 

Depreciation

 

 

(77,931

)

 

 

(74,402

)

Intangibles

 

 

(125,555

)

 

 

(119,380

)

Financing and operating lease right-of-use assets

 

 

(69,987

)

 

 

(70,385

)

Hedging

 

 

(322

)

 

 

(700

)

Pension and postretirement benefits

 

 

(143

)

 

 

 

Other

 

 

(6,793

)

 

 

(6,319

)

Deferred tax liabilities

 

 

(280,731

)

 

 

(271,186

)

Net deferred tax liability

 

$

(91,245

)

 

$

(134,832

)

 

During Fiscal 2022, the company recorded a $14.9 million deferred tax asset for the then newly effective legislation requiring capitalization of certain expenses. This enactment required expenses related to research and development activities and certain information technology costs, which were previously deductible, to be capitalized and amortized for tax purposes. The resulting cumulative deferred tax asset of $32.5 million is reflected in the 2023 balances.

In Fiscal 2023, the company recorded a deferred tax asset, in the amount of $33.4 million, related to a legal settlement accrued during the year for the repurchase of distribution rights. See Note 23, Commitments and Contingencies, for details of this settlement.

The company has a deferred tax asset of $2.2 million related to a federal net operating loss carryforward which we expect to fully utilize before expiration. Additionally, the company and various subsidiaries have a net deferred tax asset of $3.3 million related to state net operating loss carryforwards with expiration dates from Fiscal 2024 through Fiscal 2040, and $7.6 million for credit carryforwards with expiration dates from Fiscal 2027 through Fiscal 2034. The utilization of a portion of these state carryforwards could be limited in the future; therefore, a valuation allowance of $1.6 million has been recorded. Should the company determine at a later date that certain of these losses which have been reserved for may be utilized, a benefit may be recognized in the Consolidated Statements of Income. Likewise, should the company determine at a later date that certain of these net operating losses for which a deferred tax asset has been recorded may not be utilized, a charge to the Consolidated Statements of Income may be necessary. See Note 2, Summary of Significant Accounting Policies, for the deferred tax asset valuation allowance analysis.

The company did not have any unrecognized tax benefits for fiscal years 2023, 2022 and 2021. At this time, we do not anticipate significant changes to the amount of gross unrecognized tax benefits over the next twelve months.

The company accrues interest expense and penalties related to income tax liabilities as a component of income before taxes. No accrual of penalties is reflected on the company’s balance sheet as the company believes the accrual of penalties is not necessary based upon the merits of its income tax positions. The company had no accrued interest balance at December 30, 2023 and December 31, 2022.

The company defines the federal jurisdiction as well as various state jurisdictions as “major” jurisdictions. The company is no longer subject to federal examinations for years prior to 2020, and with limited exceptions, for years prior to 2019 in state jurisdictions.